跳至主要内容
临床试验/NCT01464398
NCT01464398已完成不适用

Stress Reduction for PCOS and Non-PCOS Women

Milton S. Hershey Medical Center2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2011年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86
试验地点
2
主要终点
Change from Baseline in Toronto Mindfulness Scale at 8 weeks

研究概览

简要总结

The purpose of this study is to determine the effects of stress reduction on glucose, blood pressure, quality of life and overall health and well-being in overweight or obese women, either with Polycystic Ovary Syndrome (PCOS) or without PCOS (non-PCOS). Stress reduction treatment sessions will include one or more of the following activities: breathing exercises, meditation, stretching exercises or health education activities.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women, age 18 years or older
  • Body mass index (BMI) ≥ 25 kg/m2 (overweight or obese)
  • Exclusion criteria:
  • Current pregnancy
  • Secondary causes of hyperandrogenemia, such as known or suspected androgen secreting tumors, Cushing's syndrome, or hyperprolactinemia (prolactin >30)
  • Untreated hypothyroidism or hyperthyroidism (defined as TSH <0.2 or >5.5 mIU/mL)
  • Severe active neuropsychological disorder such as psychosis or suicidal ideation
  • Severe untreated depression or anxiety. Women with severe depression or anxiety will be allowed to participate if they are under the care of a mental health specialist as long as they have permission to do so from their mental health specialist and will continue to follow-up with their mental health specialist during the study.
  • History of an inpatient admission for psychiatric disorder within the past two years
  • Active alcohol or drug abuse
  • Inability to read, speak or write English
  • Inability to commit to the intervention and follow-up
  • Current enrollment in a stress reduction program
  • Mindfulness practice within the past 6 months (regular formal practice at least once a week)
  • Current enrollment in other investigative studies
  • Type 1 diabetes

排除标准

  • 未提供

结局指标

主要结局

Change from Baseline in Toronto Mindfulness Scale at 8 weeks

时间窗: baseline and 8 weeks

次要结局

  • Change from Baseline in Hemoglobin A1c at 16 weeks(baseline and 16 weeks)
  • Change from Baseline in Mean Arterial Pressure at 16 weeks(baseline and 16 weeks)
  • Change from Baseline in Brief Symptom Inventory-18 at 16 weeks(baseline and 16 weeks)
  • Change from Baseline in Toronto Mindfulness Scale at 16 weeks(baseline and 16 weeks)
  • Change from Baseline in SF-36 at 16 weeks(baseline and 16 weeks)
  • Change from Baseline in Mean Arterial Pressure at 8 weeks(baseline and 8 weeks)
  • Change from Baseline in SF-36 at 8 weeks(baseline and 8 weeks)
  • Change from Baseline in Brief Symptom Inventory-18 at 8 weeks(baseline and 8 weeks)
  • Change from Baseline in Hemoglobin A1c at 8 weeks(baseline and 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nazia Raja-Khan

M.D., Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism

Milton S. Hershey Medical Center

研究点 (2)

Loading locations...

相似试验